Equities

American Shared Hospital Services

American Shared Hospital Services

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.19
  • Today's Change-0.043 / -1.32%
  • Shares traded6.56k
  • 1 Year change+18.15%
  • Beta0.7083
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

American Shared Hospital Services is a provider of financial and turnkey solutions to cancer treatment centers, hospitals, and large cancer networks worldwide. Its products include MR Guided Radiation Therapy Linacs, Advanced Linear Accelerators, Proton Beam Therapy systems, Brachytherapy systems, and through its GK Financing partnership with Elekta, the Leksell Gamma Knife product and services. PBRT is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. PBRT treats prostate, brain, spine, head and neck, lung, breast, gastrointestinal tract and pediatric tumors. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It typically provides the equipment and planning, installation, reimbursement and marketing support services. It also operates three fully functional turn-key radiation therapy cancer centers in Rhode Island.

  • Revenue in USD (TTM)21.62m
  • Net income in USD541.00k
  • Incorporated1983
  • Employees13.00
  • Location
    American Shared Hospital Services601 Montgomery Street, Suite 1112SAN FRANCISCO 94111United StatesUSA
  • Phone+1 (415) 788-5300
  • Fax+1 (415) 788-5660
  • Websitehttps://ashs.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AMS:ASQ since
announced
Transaction
value
Southern New England Regional Cancer Center LLC,Roger Williams Radiation Therapy LLCDeal completed10 Nov 202310 Nov 2023Deal completed45.66%2.85m
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mind Technology Inc35.54m-5.93m7.21m190.00--0.2935--0.2029-4.23-3.0525.5217.481.111.419.14187,047.40-6.70-23.74-9.36-28.4340.4533.49-6.04-40.321.41-11.880.00--51.86-6.1831.92---15.41--
Zoomcar Holdings Inc0.00-1.65m9.49m3.00--0.2344-----0.2029-0.20290.000.64410.00-------1.24---1.32--------------0.2845--------------
Getaround Inc78.32m-122.11m16.39m290.00------0.2092-1.30-1.300.8351-0.29230.4515--104.07270,055.20-70.41---114.01--90.58---155.92------1.37--22.24--16.26------
Multi Ways Holdings Ltd36.02m1.79m18.12m92.007.180.8301--0.50310.08180.08181.230.70780.65020.80335.39391,478.303.14--9.13--24.02--4.83--0.4984-2.860.187---6.11--82.92------
American Shared Hospital Services21.62m541.00k20.38m13.0039.140.89243.800.9430.08230.08233.343.610.4615--4.001,662,769.000.4911-1.580.6554-2.1744.3136.891.06-3.90--3.050.4056--8.001.58-54.07-9.8231.80--
FlexShopper Inc120.13m-8.42m23.93m204.00--3.72--0.1992-0.3269-0.32695.431.340.7811--1.55588,892.70-2.742.83-2.913.3349.0336.97-3.512.36--0.74030.8084--3.4713.73-185.08--27.04--
Generation Income Properties Inc8.73m-7.79m24.62m4.00--2.07--2.82-2.64-2.642.932.190.104--40.132,182,185.00-6.11-4.06-8.42-5.3376.6379.47-58.77-47.69---0.20080.6613--40.5086.14-91.26--22.80--
CKX Lands Inc1.46m-20.73k28.18m----1.54--19.28-0.0268-0.02680.67349.050.0806--16.95---0.11430.278-0.1160.282995.6793.39-1.424.85----0.000.0034.384.45110.85-33.69-17.85--
Grove Collaborative Holdings Inc241.26m-34.89m61.85m408.00--8.23--0.2564-0.9983-0.99836.850.45871.593.08--591,318.60-22.12---28.62--53.8247.38-13.91-32.052.92-1.380.8055---19.3619.8349.36------
Capital Properties Inc5.62m2.41m66.33m2.0027.538.7126.5811.810.3650.3530.85091.150.632----2,808,000.0027.1124.8529.7326.7283.6985.1842.9042.30----0.0092.978.870.713715.1326.84--0.00
Data as of Jun 07 2024. Currency figures normalised to American Shared Hospital Services's reporting currency: US Dollar USD

Institutional shareholders

16.04%Per cent of shares held by top holders
HolderShares% Held
Bridgeway Capital Management LLCas of 31 Mar 2024261.74k4.14%
The Vanguard Group, Inc.as of 31 Mar 2024178.67k2.82%
Dimensional Fund Advisors LPas of 31 Mar 2024171.20k2.71%
Corient Private Wealth LLCas of 31 Mar 2024160.56k2.54%
Acadian Asset Management LLCas of 31 Mar 202486.40k1.37%
Renaissance Technologies LLCas of 31 Mar 202442.30k0.67%
Financial Counselors, Inc.as of 31 Mar 202437.12k0.59%
James Investment Research, Inc.as of 31 Mar 202429.73k0.47%
NewEdge Advisors LLCas of 31 Mar 202429.73k0.47%
Geode Capital Management LLCas of 31 Mar 202417.92k0.28%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.